Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/17476348.2021.1917387 http://scihub22266oqcxt.onion/10.1080/17476348.2021.1917387 33896350!ä!33896350 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Respir+Med 2021 ; 15 (8): 1057-1060 Nephropedia Template TP {{tp|p=33896350|t=2021. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy |pdf=|usr=}}{{33896350}} gab.com Text Real-life survey on severe asthma patients during COVID-19 lockdown in Italy JO: Expert Rev Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33896350 #FOAvip Introduction: The SARS-CoV-2 pandemic has deeply revolutionized our lives and consequently the management of patients, specifically ones with severe asthma.Objective: A survey was conducted to evaluate the effects on adherence, exacerbations and quality of life in patients with severe asthma during the COVID-19 pandemic period.Methods: 100 severe asthma patients, who accepted to participate to the survey, were asked to respond to different questionnaires in order to assess asthma symptoms (Asthma Control Test - ACT, and Asthma Control Quality - ACQ) and rino-sinusal ones (Sino-nasal outcome test - SNOT-22).Results: 31 out of 100 patients reported worsening of respiratory symptoms requiring a step-up in therapy dosage or frequency during the observational period; however, exacerbation rate was very low. Only 17 (17%) of the 100 participants experienced a severe asthma exacerbation. Moreover, there was no confirmed diagnosis of COVID-19 in this population.Conclusion: Patients with severe asthma did not show higher rates of exacerbations during the pandemic outbreak as well as no increased risk of contracting COVID-19 infection or developing the disease. Self-administration of biological drugs could be useful to maintain high rates of adherence to therapy, and, at the same time, to decrease the risk of exacerbations or Intensive Care Unit (ICU) room access. Twit Text FOAVip Real-life survey on severe asthma patients during COVID-19 lockdown in Italy ????Expert Rev Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33896350 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33896350 #FOAvip English Wikipedia <ref>{{Cite pmid|33896350}}</ref> Real-life survey on severe asthma patients during COVID-19 lockdown in Italy #MMPMID33896350 Caruso C; Colantuono S; Urbani S; Heffler E; Canonica GW; Andriollo G; Di Michele L; Scarlata S; Zennaro D; Rigon A; Vadacca M; Moroni R; Nucera E; Gasbarrini A Expert Rev Respir Med 2021[Aug]; 15 (8): 1057-1060 PMID33896350show ga Introduction: The SARS-CoV-2 pandemic has deeply revolutionized our lives and consequently the management of patients, specifically ones with severe asthma.Objective: A survey was conducted to evaluate the effects on adherence, exacerbations and quality of life in patients with severe asthma during the COVID-19 pandemic period.Methods: 100 severe asthma patients, who accepted to participate to the survey, were asked to respond to different questionnaires in order to assess asthma symptoms (Asthma Control Test - ACT, and Asthma Control Quality - ACQ) and rino-sinusal ones (Sino-nasal outcome test - SNOT-22).Results: 31 out of 100 patients reported worsening of respiratory symptoms requiring a step-up in therapy dosage or frequency during the observational period; however, exacerbation rate was very low. Only 17 (17%) of the 100 participants experienced a severe asthma exacerbation. Moreover, there was no confirmed diagnosis of COVID-19 in this population.Conclusion: Patients with severe asthma did not show higher rates of exacerbations during the pandemic outbreak as well as no increased risk of contracting COVID-19 infection or developing the disease. Self-administration of biological drugs could be useful to maintain high rates of adherence to therapy, and, at the same time, to decrease the risk of exacerbations or Intensive Care Unit (ICU) room access. |*Asthma/diagnosis/drug therapy/epidemiology[MESH] |*COVID-19[MESH] |Communicable Disease Control[MESH] |Humans[MESH] |Italy/epidemiology[MESH] |Pandemics[MESH] |Quality of Life[MESH] |SARS-CoV-2[MESH]Real-life survey on severe asthma patients during COVID-19 lockdown in(epmc).pdf DeepDyve Pubget Overpricing